Navigation Links
Study Spots Gene That Plays Role in Infertility

Deleting PTEN in mice led to premature ovarian failure, researchers report

THURSDAY, Jan. 31 (HealthDay News) -- Scientists think they have discovered a mechanism that prompts early menopause and might account for some infertility problems in women.

PTEN -- a gene that's known for suppressing tumor growth -- apparently also keeps immature eggs in the ovary from ripening too quickly. When researchers deleted the PTEN gene in mice, the rodents ran out of their entire supply of eggs while they were still in the mouse equivalent of early adulthood. If ultimately applicable in humans, the revelation could lead to better infertility treatments.

"This finding is believed to have broad physiological, clinical and practical significance," said senior study author Kui Liu, an assistant professor of medical biochemistry and biophysics at Umea University, in Sweden. The report is published in the Feb. 1 issue of Science.

A woman's ovaries are made up of follicles, each of which contains an oocyte (the germ cell which will eventually give rise to an egg).

Over time, the majority of follicles remain dormant, acting as holding pens for immature oocytes. Some of these dormant follicles, however, slowly move over to the growing active follicle pool, where they are available for immediate release and, perhaps, fertilization. Menopause occurs when there are no more follicles and, therefore, no more oocytes left.

The length of a woman's reproductive life is determined by the size of her follicle pool and the rate at which this pool is depleted.

Until now, scientists have not completely understood what mechanisms are involved in this process.

For this study, Liu and colleagues deleted the PTEN gene in mice and found that these mice produced, at the most, one normal-sized litter after which they could no longer give birth. They were still in early adulthood (12 to 13 weeks of age) when they experienced this premature ovarian failure.

The same genetic variation may be responsible for premature ovarian failure in women, the authors stated. And manipulating the PTEN gene could hold hope for the future.

"Previously, it was not possible to use the sleeping primordial follicles for in vitro fertilization, as they are not able to grow up in a culture dish," Liu said. "Now that we know more about what is controlling the length of female fertility, it is also possible to culture a small slice of the ovary from an infertile woman, or a woman who will undergo chemo/radiation therapy, or an animal, and trigger the growth of primordial follicles in it by using synthetic PTEN inhibitors, and then further culture the follicles for in vitro fertilization. This means that a much richer resource of follicles can be used for in vitro fertilization."

Not only will humans potentially benefit, so might domestic animals and endangered animals that have difficulty breeding.

Future research, said Liu, will focus on finding good PTEN inhibitors.

More information

For more on fertility, visit the American Society for Reproductive Medicine.

SOURCES: Kui Liu, Ph.D., assistant professor, medical biochemistry and biophysics, Umea University, Sweden; Feb. 1, 2008, Science

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
Related Image:
Study Spots Gene That Plays Role in Infertility
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... (PRWEB) , ... November 26, 2015 , ... ... Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and ... Office in Nairobi (UNON) for the opening of the 5th African Network for ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused on ... of various clinical conditions, today announced the closing of ... Depository Shares ( ADSs ), each representing 20 ordinary ... to 3,158,900 ADSs. The ADSs and warrants were issued ...
(Date:11/25/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a developer ... Officer Antonius Schuh, Ph.D., is scheduled to present a ... Jaffray Healthcare Conference. th Annual Piper ... in New York on Tuesday, ... will be available for one-on-one meetings during the conference. ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: